FDA Forms Distribution Page for CFSAN
...Notice of Discontinuance of Commercial Distribution of Cosmetic Product Formulation.....Notification for a Food Contact Substance Formulation .. Mitchell Cheeseman .. 202-418.....Notification For New Use Of A Food Contact Substance.. Mitchell Cheeseman .. 202-205-3083..
http://www.fda.gov/opacom/morechoices/fdaforms/cfsan.html (score=100)
MDI and DPI Drug Products
...an internal reservoir containing sufficient formulation for multiple doses that are.....of each facility involved in the manufacturing of the drug substance and excipients should.....formulation, moisture level, consistency of filling operation, particle size distribution..
http://www.fda.gov/cder/guidance/2180dft.pdf (score=72)
Metered Dose Inhaler (MDI) and Dry Powder Inhaler (DPI) Drug Products...
...Whereas MDIs administer doses of the drug substance formulation to the patient without contamination.....In the case of device-metered DPIs, the particle size distribution of the drug substance within the formulation.....Energy is required for dispersion and aerosolization of the formulation and the drug..
http://www.fda.gov/CDER/GUIDANCE/2180dft.htm (score=59)
Metered Dose Inhaler (MDI) and Dry Powder Inhaler (DPI) Drug Products...
...Whereas MDIs administer doses of the drug substance formulation to the patient without contamination.....In the case of device-metered DPIs, the particle size distribution of the drug substance within the formulation.....Energy is required for dispersion and aerosolization of the formulation and the drug..
http://www.fda.gov/cder/guidance/2180dft.htm (score=59)
Statement of Daniel E. Troy, Chief Counsel, U.S. Food and Drug...
...When an NDA applicant submits a patent covering the formulation, composition, or method of.....Patents that may be submitted are drug substance (active ingredient) patents, drug product.....This includes work on issues of composition, formulation and bioequivalence. Scientific..
http://www.fda.gov/ola/2003/generic0617.html (score=59)
Greater Access to Affordable Pharmaceuticals Act
...When an NDA applicant submits a patent covering the formulation, composition, or method of.....Patents that may be submitted are drug substance (active ingredient) patents, drug product.....This includes work on issues of composition, formulation and bioequivalence. Scientific..
http://www.fda.gov/ola/2003/genericdrugs0801.html (score=59)
FDA Numerical Forms List
...Notice of Discontinuance of Commercial Distribution of Cosmetic Product Formulation.....Notification for a Food Contact Substance Formulation .. Mitchell Cheeseman ..202-418-3083.....Notification For New Use Of A Food Contact Substance.. Mitchell Cheeseman ..202-205-3083..
http://www.fda.gov/opacom/morechoices/fdaforms/default.html (score=58)
BA/BE studies for Nasal Aerosols and Nasal Sprays for Local Ac
...For an ANDA of a suspension formulation, the PSD of the active drug in the dosage form.....potency, in that release of the drug substance from the drug product should be assessed.....Nasal aerosols consist of the formulation, container, valve, actuator, dust cap..
http://www.fda.gov/cder/guidance/2070dft.pdf (score=58)
FDA Concept Paper: Drug Products That Present Demonstrable Difficulties for...
...Even slight changes in the formulation, drug substance particle size, valve, or actuator can have a major.....In addition, careful control of the impurities and degradation products in the drug substance and drug.....Other important properties of the drug substance that relate to formulation and consistency may include particle..
http://www.fda.gov/cder/fdama/difconc.htm (score=26)
stability guidance -draft
...substance or its intermediates in the drug substance manufacturing process will be.....the same formulation of the dosage form in the container and closure proposed for.....A device containing a drug substance reservoir or matrix from which drug substance..
http://www.fda.gov/cder/guidance/1707dft.pdf (score=22)
...In the case of a multi-herb substance, it is composed of the same formulation as a historical formula, with the amount of each.....In the case of a multi-herb substance, the sponsor should state whether the drug substance.....The formulation/dosage form of the botanical product used in the proposed phase 3 study..
http://www.fda.gov/cder/guidance/4592fnl.doc (score=21)
124-DERMAL TOXICITY GUIDANCE
...Also, if a particular chemical formulation is found to cause sensitization upon challenge.....Assessment of the potential dermal toxicity on a substance may include primary irritation.....After a potentially suitable formulation has been identified as a result of irritation..
http://www.fda.gov/cdrh/ode/124.html (score=21)
Guidance for Industry Botanical Drug Products
...In the case of a multi-herb substance, the sponsor should state whether the drug substance.....formulation and the individual botanical ingredients within the formulation must be.....For a botanical drug substance to be included in an OTC drug monograph, there must be..
http://www.fda.gov/cder/guidance/4592fnl.htm (score=21)
Guidance- Content & Format CMC for Vaccine & Related Product
...A discussion of any differences in formulation, manufacturing process, or site between the.....of the drug substance cannot be assured solely by downstream testing, but depends on.....If an investigational drug formulation was different from that of the to-be-marketed..
http://www.fda.gov/cber/gdlns/cmcvacc.pdf (score=20)
...From a pharmacokinetic perspective, BA data for a given formulation provide an estimate of.....BA data can also provide information indirectly about the properties of a drug substance.....Although BA studies have many pharmacokinetic objectives beyond formulation performance as..
http://www.fda.gov/cder/guidance/5356fnl.doc (score=20)
Guidance for Industry: Q3C Impurities: Residual Solvents
...If all excipients and drug substances in a formulation meet the limits given in Option 1.....Appropriate selection of the solvent for the synthesis of drug substance may enhance the.....The manufacturer could test the drug product to determine if the formulation process..
http://www.fda.gov/cber/gdlns/q3cresolvent.htm (score=20)
Guidance for Industry: Q3C Impurities: Residual Solvents
...in a formulation meet the limits given in Option 1, then these components may be used in.....Appropriate selection of the solvent for the synthesis of drug substance may enhance the.....solvents to be used in the synthesis and formulation of pharmaceutical products should be..
http://www.fda.gov/cber/gdlns/q3cresolvent.pdf (score=20)
Guideline for Submitting Supporting Documentation
...An amendment should be filed for any significant changes in formulation not proposed in.....Contract laboratories performing quality control tests on raw materials, drug substance.....The content of new drug substance indicated in the statements of composition and the..
http://www.fda.gov/cder/guidance/drugprod.htm (score=19)
/a/content.11865
...For the patent referenced above, provide the following information on the drug substance.....Drug Product (Composition/Formulation) 3.1 Does the patent claim the drug product, as.....1 Does the patent claim the drug substance that is the active ingredient in the drug..
http://www.fda.gov/opacom/morechoices/fdaforms/FDA-3542a.pdf (score=19)
...53(d) to change the formulation, add a new indication or other condition of use, change.....Drug Substance (Active Ingredient) Complete all items in this section if the patent claims.....Drug Product (Composition/Formulation) Complete all items in this section if the patent..
http://www.fda.gov/opacom/morechoices/fdaforms/FDA-3542a.doc (score=19)
Powered by viXML, providing custom search results
Las Vegas Injury Lawyer
